ESR1 and breast carcinoma: Few markers in normal tissue have been identified that predict future breast cancer risk.23–26 Of these, Ki67, a nuclear protein present in active phases of the cell cycle,27 has been most consistently linked to breast cancer risk.28–30 This association may be limited to women with low ER expression.29